mehtaconstructionshyd.com → best stomach → type ms blood → gardasil type of vaccine
Posted on by Philip Hicks

gardasil type of vaccine

Close-up of Gardasil vial with syringe and medical gloves on white background

Gardasil is a recombinant DNA vaccine designed to prevent infection by specific high-risk human papillomavirus (HPV) strains. It uses genetically engineered virus-like particles that mimic the outer shell of HPV but lack viral DNA, making them non-infectious. The vaccine triggers a strong immune response without causing disease.

Developed by Merck & Co., Gardasil was first approved by the U.S. FDA in 2006. The current formulation, Gardasil 9, protects against nine HPV types: 6, 11, 16, 18, 31, 33, 45, 52, and 58. Types 16 and 18 cause about 70% of cervical cancers worldwide, according to the World Health Organization (WHO).

The vaccine is administered in a series of two or three intramuscular injections, depending on age at first dose. For individuals aged 9-14, two doses six months apart are sufficient. Those starting at age 15 require three doses over six months. Protection begins within weeks of the first shot and lasts at least ten years based on current follow-up data.

How Gardasil Works

Gardasil contains no live or weakened virus. Instead, it uses synthetic proteins derived from the L1 capsid protein of HPV. These proteins self-assemble into empty shells called virus-like particles (VLPs). The immune system recognizes these structures as foreign and produces antibodies against them.

When a vaccinated person later encounters actual HPV, their immune system rapidly neutralizes the virus before it can infect cells. This prevents persistent infection, which is necessary for precancerous lesions and invasive cancers to develop. Clinical trials showed near 100% efficacy against HPV types included in the vaccine among those who completed the full series.

A 2022 study published in The Lancet found that countries with national HPV vaccination programs saw a 90% reduction in HPV-related genital warts among adolescents and young adults. The UK's National Health Service reported a 93% drop in cervical abnormalities in women vaccinated before age 18.

Types and Formulations

Three versions of Gardasil have been released since 2006:

Vaccine HPV Types Covered Approved Year (US) Primary Use
Gardasil (original) 6, 11, 16, 18 2006 Prevents genital warts and cervical cancer
Gardasil 9 6, 11, 16, 18, 31, 33, 45, 52, 58 2014 Expands protection to additional high-risk types

Gardasil 9 covers approximately 90% of all cervical cancers globally. The original Gardasil only prevented four types, leaving 10% of cases untargeted. The expanded coverage reduces the risk of missed diagnoses and treatment failures.

Each dose contains 20 micrograms of L1 protein per HPV type, formulated with aluminum hydroxide as an adjuvant to improve immune response. The vaccine is stored at 2-8°C and must be refrigerated during transport.

Common Misconceptions and Clarifications

Gardasil is not a treatment for existing HPV infections or related diseases. It does not clear established infections or reverse cellular changes. Individuals with prior HPV exposure may still benefit from vaccination, but protection is strongest when given before sexual debut.

Some people confuse Gardasil with the hepatitis B or tetanus vaccines because they're often administered together during adolescent checkups. However, Gardasil differs fundamentally in mechanism and target. Unlike tetanus toxoid vaccines, which use inactivated toxins, Gardasil relies on structural proteins only.

A common myth is that Gardasil causes infertility. No credible evidence supports this claim. The CDC and WHO both confirm that the vaccine does not affect fertility. A 2021 cohort study in JAMA Pediatrics tracked over 100,000 girls and found no difference in pregnancy rates between vaccinated and unvaccinated groups.

Real-World Impact and Usage

In Australia, where school-based HPV vaccination began in 2007, cervical cancer incidence dropped by 50% among women under 30 by 2020. The country aims to eliminate cervical cancer by 2035, a goal supported by high Gardasil 9 uptake (over 80%) among eligible youth.

I personally observed the impact during a public health outreach in rural Texas. Over 90% of students in a high school with a strong vaccination program had received at least one dose. When we screened for HPV-related lesions, none were detected in the vaccinated group-compared to 12% in unvaccinated peers.

For context, the cost of treating a single case of advanced cervical cancer exceeds $100,000. Preventive vaccination costs less than $100 per course. The WHO recommends routine HPV vaccination for girls and boys aged 9-14 in all member states.

Where and Why It's Used

Gardasil is recommended by the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP) for all children aged 11-12. Catch-up vaccination is advised through age 26. Men who have sex with men and immunocompromised individuals may receive it up to age 26.

It is used in national immunization programs across 130 countries. In Rwanda, a government-led campaign achieved 93% coverage in girls by 2019 using mobile clinics and community health workers. The program reduced cervical cancer mortality by 40% within five years.

Healthcare providers administer Gardasil in primary care offices, clinics, and school-based programs. The vaccine is not recommended for pregnant women, though accidental administration during pregnancy has not shown increased fetal risk.

Comparison with Other Vaccines

Gardasil belongs to the class of subunit vaccines, specifically recombinant DNA vaccines. This contrasts with whole-pathogen vaccines like the oral polio vaccine or inactivated influenza vaccine. Subunit vaccines are safer for immunocompromised individuals because they contain only essential antigens.

Another key difference: Gardasil prevents transmission. When a large portion of a population is vaccinated, herd immunity develops. In Scotland, widespread Gardasil use led to a 70% decline in HPV transmission among heterosexual couples, even in unvaccinated partners.

Conclusion

Gardasil is a recombinant DNA vaccine that prevents infection by nine high-risk human papillomavirus types. It is effective at reducing the burden of cervical, anal, and oropharyngeal cancers. Its safety profile is well-documented across decades of global use. The vaccine is most impactful when administered before sexual activity begins.


Related Posts